Celleration Inc., an Eden Prairie, Minn.-based maker of a non-contact ultrasound device for medical applications like wound-care, has expanded its Series D round from $25 million to $30 million, according to a regulatory filing. Shareholders include Venture Investors LLC, Upper Lake Growth Capital, Baird Venture Partners, Aavin Equity Advisors, Triathlon Medical Ventures and New Science Ventures.
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.